Aurora kinase B expression in breast carcinoma: cell kinetic and genetic aspects K Hegyi, K Egervári, Z Sándor, G Méhes Pathobiology 79 (6), 314-322, 2012 | 74 | 2012 |
Genome wide analysis of TLR1/2-and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands D Törőcsik, D Kovács, S Póliska, Z Szentkereszty-Kovács, M Lovászi, ... PloS one 13 (6), e0198323, 2018 | 34 | 2018 |
Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy K Hegyi, G Méhes Pathology & Oncology Research 18, 761-769, 2012 | 30 | 2012 |
Factor XIII-A in diseases: role beyond blood coagulation K Dull, F Fazekas, D Törőcsik International Journal of Molecular Sciences 22 (3), 1459, 2021 | 18 | 2021 |
Occurrence and molecular pathology of high grade gliomas B Murnyák, T Csonka, K Hegyi, G Méhes, A Klekner, T Hortobágyi Ideggyogyaszati Szemle 66 (9-10), 312-321, 2013 | 17* | 2013 |
Epidermal growth factor modulates palmitic acid-induced inflammatory and lipid signaling pathways in SZ95 sebocytes D Törőcsik, F Fazekas, S Póliska, A Gregus, EA Janka, K Dull, A Szegedi, ... Frontiers in Immunology 12, 600017, 2021 | 13 | 2021 |
Isotretinoin is indirectly effective in sebocytes D Kovács, K Hegyi, A Szegedi, D Deák, S Póliska, R Rühl, CC Zouboulis, ... British Journal of Dermatology 182 (4), 1052-1054, 2020 | 10 | 2020 |
One-day FISH approach for the high-speed determination of HER2 gene copy status in breast carcinoma K Hegyi, C Lønborg, A Mónus, G Méhes Applied Immunohistochemistry & Molecular Morphology 21 (6), 567-571, 2013 | 10 | 2013 |
miR-146a modulates TLR1/2 and 4 induced inflammation and links it with proliferation and lipid production via the indirect regulation of GNG7 in human SZ95 sebocytes K Dull, F Fazekas, D Deák, D Kovács, S Póliska, A Szegedi, CC Zouboulis, ... Scientific reports 11 (1), 21510, 2021 | 9 | 2021 |
Mitotic index determined by phosphohistone H3 immunohistochemistry for precise grading in follicular lymphoma J Bedekovics, G Irsai, K Hegyi, L Beke, L Krenács, L Gergely, G Méhes Applied Immunohistochemistry & Molecular Morphology 26 (8), 579-585, 2018 | 9 | 2018 |
Primary uterine NK-cell lymphoma, nasal-type: a unique malignancy of a prominent cell type of the endometrium G Méhes, K Hegyi, T Csonka, F Fazakas, Z Kocsis, G Radványi, I Vadnay, ... Pathology & Oncology Research 18, 519-522, 2012 | 7 | 2012 |
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin K Dull, K Lénárt, Z Dajnoki, S Póliska, E Uchiyama, Z Hendrik, A Szegedi, ... Journal of the European Academy of Dermatology and Venereology 37 (7), 1415-1425, 2023 | 3 | 2023 |
Distinct Dynamics of Mitotic Transition in B-Cell Lymphoma and Reactive B-Cell Lymphoproliferations Determined by H3S10 Phosphohistone Immunolabeling G Méhes, K Hegyi, R Jobanputra, L Beke, G Vereb, J Bedekovics Pathobiology 84 (5), 243-250, 2017 | 3 | 2017 |
Mutant KRAS status is associated with increased KRAS copy number imbalance: a potential mechanism of molecular heterogeneity O Dócs, K Hegyi, A Mokánszky, A Mónusné, L Beke, C András, ... Pathology & Oncology Research 23, 417-423, 2017 | 3 | 2017 |
Linoleic Acid Induced Changes in SZ95 Sebocytes—Comparison with Palmitic Acid and Arachidonic Acid D Kovács, E Camera, S Póliska, A Cavallo, M Maiellaro, K Dull, F Gruber, ... Nutrients 15 (15), 3315, 2023 | 2 | 2023 |
Effect of a polyanion macromolecule on mitochondria DNA synthesis in isolated rat liver mitochondria. G Szabados, V Ádám-Vizi, K Hegyi, I Horváth Acta biochimica et biophysica; Academiae Scientiarum Hungaricae 14 (3), 155-164, 1979 | 2 | 1979 |
New Data on the Features of Skin Barrier in Hidradenitis Suppurativa O Somogyi, Z Dajnoki, L Szabó, K Gáspár, Z Hendrik, CC Zouboulis, ... Biomedicines 11 (1), 127, 2023 | 1 | 2023 |
Down‐regulation of increased TRAF 6 expression in the peripheral mononuclear cells of patients with primary Sjögren's syndrome by an EBV‐EBER 1‐specific synthetic single … S Sipka, E Zilahi, G Papp, JQ Chen, A Nagy, K Hegyi, J Kónya, M Zeher International Journal of Rheumatic Diseases 20 (5), 614-621, 2017 | 1 | 2017 |
Biologic mechanisms of mitotic abnormalities and chromosome number changes in malignant tumors K Hegyi Magyar Onkologia 59 (4), 365-371, 2015 | 1 | 2015 |
Mitotic kinase Aurora B is frequently overexpressed in aggressive B-cell lymphoma K Hegyi, J Bedekovics, O Docs, G Irsai, L Gergely, L Beke, G Mehes World Journal of Pathology 4 (4), 2015 | 1 | 2015 |